Vakharia D D, Dias J A, Andersen T T
Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany 12201.
Endocrinology. 1991 Apr;128(4):1797-804. doi: 10.1210/endo-128-4-1797.
Three different experimental approaches were used to assess the regions on the beta-subunit of human FSH (hFSH beta) that may be altered or masked by its association with the alpha-subunit of hFSH (hFSH alpha) in the heterodimeric hFSH molecule. In a direct approach, we tested whether synthetic peptides corresponding to hFSH beta sequences 1-20, 16-36, 33-53, 49-67, 66-85, 81-100, and 98-111 inhibited association of hFSH alpha and hFSH beta in an enzyme-linked immunosorbent assay. Synthetic peptides-(81-100), -(98-111), and -(66-85) caused greater than 50% inhibition of subunit association, whereas other peptides showed 26% or less inhibition. These data suggested that the C-terminal sequences of hFSH beta, particularly 81-100, are at a subunit interface with hFSH alpha in heterodimeric hFSH. In another approach we reasoned that antibodies with a higher affinity for free hFSH beta than for heterodimeric hFSH bind to epitopes on hFSH beta that are masked or altered by hFSH alpha subunit. To test this hypothesis, epitopes of hFSH beta were mapped using synthetic peptides of hFSH beta sequences, three monoclonal antibodies (3G3, 4D5, and 4G8), and a polyclonal antiserum (NIDDK anti-hFSH beta). Compared to 3G3 all the other antibodies exhibited minimal reactivity with hFSH, but bound strongly to hFSH beta. The epitope-mapping data with both 4D5 and NIDDK anti-hFSH beta identified peptide 81-100, which was not recognized by 3G3. The epitope map with 4G8 identified the same three peptides as with 3G3. However, in the case of 4G8 its reactivity with peptide 33-53 was the least, whereas it was ranked first for 3G3. Since both 3G3 and 4G8 had an identical affinity for hFSH beta, it was hypothesized that sequences in peptide 33-53 may be altered or masked by hFSH alpha. To test this, we determined the specificity of anti-hFSH beta-(33-53) peptide antiserum for hFSH beta and hFSH in an enzyme-linked immunosorbent assay. The antipeptide antiserum bound strongly to free hFSH beta and weakly to hFSH, suggesting that part of the sequence in peptide-(33-53) was masked or altered by association with hFSH alpha in heterodimeric hFSH. Taken together, the subunit association studies, the epitope-mapping data, and the specificity of anti-hFSH beta-(33-53) peptide antiserum have suggested that sequences in peptide-(81-100) and -(33-53) are masked or conformationally altered by hFSH alpha in heterodimeric hFSH.
采用三种不同的实验方法来评估人促卵泡激素(hFSH)β亚基上可能因与异源二聚体hFSH分子中的hFSHα亚基结合而发生改变或被掩盖的区域。在直接法中,我们在酶联免疫吸附测定中测试了对应于hFSHβ序列1 - 20、16 - 36、33 - 53、49 - 67、66 - 85、81 - 100和98 - 111的合成肽是否能抑制hFSHα和hFSHβ的结合。合成肽 -(81 - 100)、 -(98 - 111)和 -(66 - 85)对亚基结合的抑制率大于50%,而其他肽的抑制率为26%或更低。这些数据表明,hFSHβ的C末端序列,特别是81 - 100,在异源二聚体hFSH中是与hFSHα的亚基界面。在另一种方法中,我们推断对游离hFSHβ亲和力高于对异源二聚体hFSH亲和力的抗体,会结合到hFSHβ上被hFSHα亚基掩盖或改变的表位。为了验证这一假设,使用hFSHβ序列合成肽、三种单克隆抗体(3G3、4D5和4G8)以及一种多克隆抗血清(NIDDK抗hFSHβ)绘制hFSHβ的表位图谱。与3G3相比,所有其他抗体与hFSH的反应性最小,但与hFSHβ结合强烈。4D5和NIDDK抗hFSHβ的表位图谱数据都确定了肽81 - 100,而3G3不识别该肽。4G8的表位图谱确定的三种肽与3G3相同。然而,就4G8而言,其与肽33 - 53的反应性最低,而在3G3中该肽的反应性最高。由于3G3和4G8对hFSHβ的亲和力相同,因此推测肽33 - 53中的序列可能被hFSHα改变或掩盖。为了验证这一点,我们在酶联免疫吸附测定中确定了抗hFSHβ -(33 - 53)肽抗血清对hFSHβ和hFSH的特异性。抗肽抗血清与游离hFSHβ结合强烈,与hFSH结合较弱,这表明肽 -(33 - 53)中的部分序列在异源二聚体hFSH中因与hFSHα结合而被掩盖或改变。综合亚基结合研究、表位图谱数据以及抗hFSHβ -(33 - 53)肽抗血清的特异性表明,在异源二聚体hFSH中,肽 -(81 - 100)和 -(33 - 53)中的序列被hFSHα掩盖或构象改变。